Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label angiogenesis. Show all posts
Showing posts with label angiogenesis. Show all posts
Monday, February 20, 2012

ELC : Investigator Insights: VEGF and VEGFR Inhibitors in Gynecologic Malignancies

›
  Blogger's Note: requires registration CME expires 2013 Investigator Insights: VEGF and VEGFR Inhibitors in Gynecologic Malign...
Monday, January 30, 2012

links to article/commentary/blogger's notes: Intravenous Aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study : The Lancet Oncology

›
Blogger's Note :  reposted from Jan 20th due to Lancet Editorial and reference - paper is open accdess pay specific attentio...
Thursday, January 26, 2012

video: CFS Nov 2011: Active angiogenesis drugs in development - Prof Bradley Monk – University of California Irvine, USA

›
Wednesday, July 27, 2011

Contemporary Approaches in Targeting Angiogenesis | prIME Oncology

›
Topics Module One : Concepts in Angiogenesis Inhibition Module Two : Biomarkers in Angiogenesis Module Three : Optimizing Outcomes with...
Wednesday, May 05, 2010

Abstract/full access; TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients

›
Abstract (provisional) Background Angiogenesis appears to play an important role in ovarian cancer. Vascular endothelial growth fact...
Wednesday, January 27, 2010

Inherited Determinants of Ovarian Cancer Survival

›
" Conclusion : An extensive multiple-pathway assessment found evidence that inherited differences may play a role in outcome of ovarian...